Precision Medical, Inc., headquartered in the United States, is a leading innovator in the medical device industry, specialising in respiratory care and anaesthesia products. Founded in 1982, the company has established a strong presence across North America and Europe, consistently delivering high-quality solutions that enhance patient care. With a diverse portfolio that includes oxygen concentrators, flowmeters, and medical gas equipment, Precision Medical stands out for its commitment to reliability and user-friendly design. The company has achieved significant milestones, including numerous patents and industry awards, solidifying its position as a trusted partner in healthcare. Precision Medical continues to set the standard for excellence, ensuring that healthcare professionals have access to the best tools for patient management.
How does Precision Medical, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Machinery and Equipment industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Precision Medical, Inc.'s score of 18 is lower than 70% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Precision Medical, Inc., headquartered in the US, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. This lack of data suggests that Precision Medical may not have established formal commitments to reduce its carbon footprint or engage in climate initiatives at this time. As the industry increasingly prioritises sustainability, it will be essential for Precision Medical to consider developing and communicating its climate commitments to align with broader environmental goals.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Precision Medical, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
